PAR-2激动剂对肝癌细胞增殖及Ca^(2+)水平的影响  

Effects of PAR-2 agonist peptide on proliferation and cytosolic calcium level in hepatoma cells

作　　者：郑艳敏[1] 谢立群[1] 赵军艳[1] 李轩[1] 陈小义[2] 陈莉[2] 周静[1] 李飞[1] 

机构地区：[1]武警医学院附属医院消化内科,天津300162 [2]武警医学院细胞生物学教研室,天津300162

出　　处：《中国病理生理杂志》2009年第12期2371-2375,共5页Chinese Journal of Pathophysiology

摘　　要：目的:研究PAR-2激动剂对人肝癌HepG2细胞增殖及细胞内Ca2+浓度([Ca2+]c)的影响。方法:培养人肝癌细胞HepG2,分别利用PAR-2激动剂SLIGKV-NH2及反PAR-2激动肽VKGILS-NH2干预肝癌细胞生长,用Fura-2荧光法测定肝癌细胞内[Ca2+]c,用MTT法检测对肝癌细胞增殖能力的影响,流式细胞术(FCM)检测细胞周期改变情况,RT-PCR法检测cyclin D1 mRNA表达变化。结果:50μmol/LSLIGKV-NH2刺激HepG2细胞后,[Ca2+]c迅速短暂升高(P<0.01);G0/G1期比例明显降低,S期和G2/M期细胞比例和细胞增殖指数(PI)明显提高(P<0.01);cyclin D1 mRNA的表达显著增加(P<0.01)。SLIGKV-NH2在1-50μmol/L时可以促进HepG2细胞增殖,呈剂量依赖性(P<0.01或P<0.05)。而VKGILS-NH2组与对照组相比差异无显著(P>0.05)。结论:PAR-2激动剂在体外能通过激活PAR-2,诱导HepG2细胞内[Ca2+]c升高,上调cyclin D1 mRNA的表达,加速HepG2细胞周期进程,促进DNA合成,促进肝癌细胞增殖。AIM： To investigate the effects of PAR -2 agonist peptide on the proliferation and cytosolic calcium concentration （ [ Ca^2 ＋ ] c ） in human hepatoma cells HepG2. METHODS ： Human hepatoma cell line HepG2 was cul- tured. The cells were treated with PAR - 2 agonist peptide SLIGKV - NH2 and the reverse PAR - 2 agonist peptide VKGILS - NH2, respectively. The [ Ca2＋] c of hepatoma cells were measured by microflnorimetric techniques based on cal- cium indicator fura - 2/AM. The influences on proliferation of hepatoma cells were determined by MTT method. The changes of cell cycle were evaluated by flow cytometry, and the changes of cyclin D1 mRNA expression were detected by RT - PCR. RESULTS： After treated with 50 μmol/L SLIGKV - NH2, a rapid rise of [ Ca2＋]c in HepG2 cells was induced （P 〈 0. 01 ）, percent S phase, G2/M phase and proliferation index （PI） of HepG2 cells were elevated （P 〈 0. 01 ）, and cyclin D1 mRNA expression was significantly upregulated （P 〈 0. 01 ）. The proliferation rates of HepG2 cells treated with 1 - 50 μmol/L SLIGKV - NH2 were significantly increased, and the effect was in a dose - dependent manner （P 〈0. 01 or P 〈 0. 05 ）. No statistical significance of the difference between VKGILS - NH2 and control group was observed （ P 〉 0. 05 ）. CONCLUSION： PAR - 2 agonist peptide induces the rise of [ Ca2＋] c in HepG2 cells, upregulates the expression of cyclin DI mRNA, accelerates the progress of cell cycle, promotes the synthesis of DNA and the proliferation of hepatoma cells via activating PAR -2 in vitro.

关 键 词：蛋白酶激活受体-2 HEPG2细胞 细胞增殖 钙 

分 类 号：R735[医药卫生—肿瘤]